Inhibition of the PGAM1-CHK1 Interaction as a Novel Approach to Destroy Senescent Cells
Key claim: Inhibiting the PGAM1–CHK1 interaction sabotages the elevated glycolysis of senescent cells and offers a novel way to selectively destroy them.
Abstract
The accumulation of senescent cells is an important contribution to degenerative aging; the inflammatory secretions of senescent cells actively degrade tissue structure and function. Animal studies have shown that selective destruction of senescent cells produces a meaningful degree of rejuvenation in old animals, alongside reversal of the pathology and progression of many age-related conditions. Senescent cells exhibit a sizable number of metabolic differences from normal cells, and researchers continue to explore these differences in search of novel ways to selectively destroy senescent cells. Here find an example of a novel finding, in which researchers explore the increased glycolysis that supports senescent cell energy metabolism and find a way to sabotage it. Aging is a complex biological process, which is affected by several factors, lifestyle, diet, […]
Why this matters
Adds a metabolic-vulnerability route to the senolytic roster: senescent cells’ upregulated glycolysis depends on a PGAM1–CHK1 interaction whose disruption is proposed to kill them selectively. This diversifies the mechanistic menu beyond BCL-2 family (ABT-263), tyrosine-kinase/flavonoid (D+Q), Na⁺/K⁺-ATPase (Tubeimoside I), and PCC1 approaches, but the evidence remains preclinical and communicated through secondary coverage rather than a primary human readout.